ReviewClinical ophthalmology (Auckland, N.Z.)2024

Evidence in Practice: A Review of Real-Life Studies and Clinical Experience with the Preservative-Free Tafluprost (0.0015%) and Timolol (0.5%) Fixed-Dose Combination.

Gábor HolloPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.